Howard W. Robin, President & CEO at NEKTAR THERAPEUTICS (NKTR), sold 76,028 shares at $3.57 ($271K) on 2022-11-16, disclosed to the SEC on 2022-11-18.
Seasonal sale ($271k) by President & CEO — this insider has traded NKTR in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.57 | 38,014 | $136K | 50.0% |
| 2 | $3.57 | 38,014 | $136K | 50.0% |
| Total | $3.57 avg | 76,028 | $271K | 100% |
| Filing → |
| NKTR | SELL | 2026-05-21 | $29K | — | Filing → |
| NKTR | SELL | 2026-02-20 | $31K | — | Filing → |
| NKTR | SELL | 2025-11-25 | $240K | — | Filing → |